Hong Seng, Mediven to Broaden Reach in Healthcare Products and Services

May 2022

Malaysia’s leading healthcare industry supply chain management provider, Hong Seng Group through its subsidiary, HS Bio Sdn Bhd, has agreed to collaborate with Mediven Innovation Ventures (Mediven) to jointly work on the supply of healthcare products and services.

The companies will evaluate potential markets and opportunities for their products and may jointly pursue tenders and bids for projects by offering a more comprehensive range of solutions. Hong Seng Executive Mediven Operations Director Dr. Lim Li Sze remarked that both parties intend to build up substantial contributions to enhance health and address infectious diseases.

HS Bio covers a wide range of healthcare solutions including digital health, laboratory testing, R&D, and medical supplies. The firm and its healthcare subsidiaries have also extended their healthcare business from providing 3rd party and 4th party logistics services to the entire end-to-end healthcare supply chain. Mediven is a molecular diagnostics designer and supplier of GenoAmpTM and ProDetectTM series of products, which are mainly used for infectious diseases.

(Sources: The Edge Markets; New Straits Times)

About Us

Orissa International helps companies that want to develop a market entry strategy for Southeast Asia or implement their business expansion into the region. We have very strong domain knowledge of markets and industry sectors, and a business network of over 16,000 companies that includes distributors, resellers, system integrators and local manufacturers, that we have built through advising and guiding more than 5,000 companies with their market expansion into the ASEAN region over the last 25 years.

Orissa International is headquartered in Singapore, with additional offices in Malaysia, Indonesia, Thailand, Vietnam, and the Philippines.

Our Services